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Abstract. Caprine milk CSN1S2 protein contains bioactive peptides that have a 
specific function in regulating the metabolic homeostasis mechanism between 
different organs. However, the safe dosage of goat milk consumption has not 
been established previously. The aim of this study was to evaluate the safe 
dosage of caprine CSN1S2 protein from fresh local goat milk using acute and 
repeated doses (for 4 weeks) in oral toxicity studies on three month old normal 
Wistar rats. The CSN1S2 protein was isolated from fresh goat milk. This casein 
protein administered in a single oral gavage dose to 5 rat groups at a daily dose 
of 0, 500, 1000, 2000, 4000 mg/kg BW for acute and 28-day sub-chronic toxicity 
testing of rats of both sexes. The result showed no evident mortality or abnormal 
effects. Data analysis of body weight, water and food intake, blood biochemical 
parameters, clinical observation and organ weight revealed no significant 
differences between all groups for both sexes. The weights of some organs 
showed differences between groups, but these values were within the normal 
weight ranges. The conclusion is that caprine CSN1S2 from fresh milk is safe for 
food consumption because there was no indication of toxicity, no mortality, and 
no hematological and clinical chemistry changes. 
Keywords: acute; caprine CSN1S2; goat milk; sub-chronic; toxicity test. 
1 Introduction 
Milk protein consists of alpha-S1 and alpha-S2 casein, and beta- and kappa-
casein. There are bioactive peptides that are able to reduce the risk of diseases 
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or to enhance physiological functions as functional foods and/or nutraceuticals 
[1,2]. Our previous study identified eight bioactive peptide residues in alpha-S2 
casein of goat (caprine) milk with a specific function [3]. Whole and 
electrophoretic casein fractions of goat milk have been shown to exhibit 
different biological activities. Goat milk protein is provided as healthy nutrition 
and as a therapeutic agent to control abnormal or disease conditions through 
some of its biologically active peptide residues [4]. Alpha-S2 casein (CSN1S2) 
protein of goat milk has a biological function due to its anti-oxidant, anti-
osteoporotic, anti-inflammatory activities, or as an immunomodulatory agent to 
prevent immune system failure and homeostasis of metabolic mechanisms, 
respectively [4-6]. Another study explained that goat milk supplementation was 
also able to protect and reduce the severity of carcinogenesis in 
hepatocarcinogenesis-induced rats [7]. 
An important requirement for toxicological experiments on animals is the 
ability to estimate the effects of the treatment on specific organs. Indicators are 
a body and organ weight, and histopathological, hematological and biochemical 
blood parameters. The most sensitive indicator of the effects of experimental 
treatment with casein protein are significant differences in organ weight 
between treated and control animals in the absence of any morphological 
changes. The standard for toxicological evaluation of safety in pre-clinical 
models can be applied [8]. Biochemical indicators monitoring animal organs 
such as the liver and kidneys can identify biological markers of tissue damage. 
The assessment of various enzyme activities in the tissues and body fluids may 
play a significant role in measuring the effects of molecular compounds related 
to disease investigation [9,10]. The blood is an analytical subject that is an 
important indicator of pathological and physiological states in humans and 
animals. The differentiation of body and organ weight within normal ranges is 
not associated with variations of hematological parameters causing a lack of 
clear-dose response [11]. 
Our previous study also showed that doses of goat milk casein protein at 500, 
1000, 1500 and 2000 mg/kg body weight did not result in abnormal 
microstructure and mineral contents after a month of daily consumption [12]. 
Although the biological activity of caprine CSN1S2 protein from fresh milk has 
been revealed, there are no studies available that examined the toxicity of 
caprine CSN1S2 protein from fresh milk. Therefore, this study aimed to 
evaluate acute and 28-day sub-chronic toxicity studies of caprine CSN1S2 
protein from fresh goat milk in normal Wistar rats. 
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2 Materials and Methods 
2.1 Animal Experiments 
In this study, we used 25 male and 25 female, 8-week old Wistar rats, obtained 
from the Experimental Animal Laboratory, UPT LPPT, Universitas Gadjah 
Mada, Yogyakarta. The animals were acclimatized for a week in the 
Experimental Animal Laboratory, Biosains Institute, at Universitas Brawijaya, 
Malang (conditions prior to experimental manipulation). The rats used as 
experimental animals were individually housed in polycarbonate metabolic 
cages and room conditions were maintained (temperature 25 °C, 60% humidity 
and light-dark cycle 12 hours). The animals had free access to a standard 
commercial pellet diet and water ad libitum.  The conditions and handling of all 
animals were approved by the Brawijaya University ethical research committee 
(Ethical Clearance Certificate No. 205-KEP-UB). 
2.2 Preparation of Caprine CSN1S2 Protein of Fresh Goat Milk 
Caprine Alpha-S2 casein protein was isolated from 250 ml of fresh milk 
samples from local Ethawah goats, which had been heated to a temperature of 
40 °C using a water bath. Glacial acetic acid was added to the milk while 
stirring until casein precipitate was formed. The caprine Alpha-S2 casein 
protein was purified by slightly modified standard method [3]. The protein 
precipitation was then separated by filtration through a nylon mesh [3,5]. The 
protein content was measured using a Nano-Drop UV-Vis spectrophotometer, 
after which the protein was stored at -20 °C.  
2.3 Administration of Caprine CSN1S2 Protein from Fresh Milk 
for Acute Toxicity Study 
Fifty rats (25 males, 25 females) were divided into five groups (5 males and 5 
females in each group): control (untreated) rats 0 mg/kg BW (AMC0/AFC0), 
and rats treated with CSN1S2 protein at doses of 500 mg/kg BW 
(AMC500/AFC500), 1000 mg/kg BW (AMC1000/AFC1000), 2000 mg/kg BW 
(AMC2000/AFC2000), and 4000 mg/kg BW (AMC4000/AFC4000), 
respectively. The rats were fasted overnight before treatment. The caprine 
CSN1S2 protein from fresh milk was orally administered at proper doses (as 
specified below) daily for 14 days, and the control group was given the same 
volume of vehicle [12]. Single oral gavage doses of caprine CSN1S2 protein 
from fresh milk (500, 1000, 2000, and 4000 mg/kg BW) were dissolved in d-
water according to the previous study, with dose modification [13]. The treated 
groups were administered with casein in individual cages based on the 
individual animal body weight obtained on the day of dosing. Symptoms of 
toxicity, behavioral changes, mortality, and weight changes were monitored on 
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a daily basis. Finally, the rats were weighed, euthanized, and necropsied on day 
15.  Mortality and clinical symptoms were observed in a sustainable manner in 
0, 1, 2, 3, 4, 5, and 6 hours after dosing on the first day and once per day from 
day 2 into day 15. The animals were weighed before being dosed (day 1) and 
after dosing (day 2, 4, 8, and 15) using electronic scales (Sartorius Co., 
Germany). At the end of each treatment, the rats were given sodium 
pentobarbital anesthesia (intraperitoneal injection) and their blood was collected 
from the carotid arteries in heparized and nonheparinized tubes for 
hematological and biochemical examination of the serum. After collection of 
the blood, the internal organs were isolated and weighed to determine the 
relative organ weight and to know the gross lesions. 
2.4 Sub-chronic Toxicity Inspection for 28 Days 
A study of 28-day sub-chronic toxicity was done according to the Organization 
for Economic Cooperation and Development (OECD) Guideline 425 adopted 
on the 3rd of October 2008 and the institutional animal ethics guideline [14]. 
The casein protein from goat milk was orally administered at proper doses, i.e. 
0 mg/kg BW, 500 mg/kg BW, 1000 mg/kg BW, and 2000 mg/kg daily for 28 
days, while the control group was given the same volume of vehicle. The rats 
were then randomly divided into four groups, each group consisting of 6 males 
(M) and 6 females (F), with a total of 48 rats. Mortality and clinical signs were 
recorded once per day during the study period using the Path/Tox program (Ver 
4.2.2). The experimental animals were weighed on the day of arrival, randomly 
on the first day of treatment dose, then once a week and at the end of the 
experiment. External eye examination was done during the pretest period. 
External and fundus examination were performed using a binocular indirect 
opthalmoscope (Vantage Plus Digital, Keeler Ltd., UK). At the end of each 
treatment, the rats were given sodium pentobartial anesthesia (intra-peritoneal 
injection) and blood was collected from the carotid arteries in heparized and 
non-heparinized tubes for hematological and biochemical examination of the 
serum. After collection of the blood, the internal organs were isolated and 
weighed to determine the relative organ weight and know the gross lesions. 
2.5 Hematology and Serum Biochemistry 
All test animals were fasted overnight before necroscopy and taking blood. The 
animals were then given isoflurane anesthesia via inhalation, blood samples 
were taken before the animals were killed by exsanguination of the aorta. Blood 
samples were collected in tubes containing EDTA-2K and the complete blood 
cell count was obtained. The blood cells were measured using a ADVIA 120 
Hematology System (Bayer, USA). Prothrombin time (PT) and activated-
partial-thromboplastin time (APTT) were analyzed. The blood samples were 
treated with 3.2% sodium citrate using a Beckman ACL 9000 coagulation 
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analyzer. Blood samples were collected from the vena cava posterior from all 
experimental animals for the biochemical and hematological examination, 
which was conducted according to the OECD Guidelines [13,14]. Serum 
samples were prepared after centrifugation of the blood and analyzed using an 
NEO 200FR Toshiba (Toshiba Co., Japan). The biochemical parameters 
measured were: aspartate aminotransferase (AST, IU/dL), alanine 
aminotransferase (ALT, IU/dL), alkaline phosphatase (ALP, IU/dL), blood urea 
nitrogen (BUN, mg/dL), creatinine (mg/dL), glucose (mg/dL), total cholesterol 
(TCHO, mg/dL), total protein (g/dL), triglyceride (TG, mg/dL), uric acid 
(mg/dL), and bilirubin (mg/dL).  The hematological parameters measured were: 
white blood cells (WBC) (x103/µL), platelet (x103/µL), red blood cell (RBC) 
(x106/µL), hemoglobin (g/dL), hematocrit (%), mean corpuscular volume 
(MCV) (fL), mean corpuscular hemoglobin (MCH) (pg), and mean corpuscular 
hemoglobin concentration (MCHC) (g/dL). 
2.6 Organ Weight Measurement 
The absolute organ weights and relative organ weights (organ/body weight) 
were calculated for all organs from all the experimental animals that were 
killed. Absolute organ weights (g) were measured, including the brain, heart, 
liver, spleen, kidneys, thymus, lungs, adrenals, testes, ovaries, stomach and 
intestines. 
2.7 Statistical Analysis 
Data are presented as mean ± SD and differences between groups were analyzed 
using an ANOVA test with SPSS 16.0 software. A probability value of P < 0.05 
was considered statistically significant and P < 0.05 for all data analyses. 
3 Results 
3.1 Characterization of Rats’ Body Weight, Water & Food Intake 
and Respiratory Rate 
The caprine casein protein was isolated from fresh goat milk as proper. In this 
14-day acute toxicity test, the effect of goat milk casein at different 
concentrations on rats was observed. The rats’ body weight gain developed 
normally in both sexes. Statistical analysis for all treatment groups showed that 
there was no significant difference between groups (P > 0.05) (Figure 1). 
Water and food intake of the rats treated with CSN1S2 protein goat milk in the 
14-day acute toxicity test in all groups was slightly up and down. Food intake at 
the doses of 1000 and 2000 mg/kg BW was significantly lower compared to 
control and at the dose of 500 mg/kg BW. At the dose of 4000 mg/kg BW it 
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was significantly higher compared to the dose of 1000 mg/kg BW. However, it 
is assumed that food consumption was still within the common daily range. 
Further, in order to identify respiratory distress, according to common signs 
shown by small animals, the respiratory rate was measured. The data for all 
animal groups did not show any symptoms related to the respiratory distress 
syndrome.  
 
Figure 1 Body weight of rats treated with Caprine CSN1S2 protein from fresh 
milk in acute toxicity test over 14 days. A and B: body weight of female rats. C 
and D: body weight of male rats. AFC0 = acute female zero dose of CSN1S2 
Protein goat milk; AFC500 = acute female 500 mg/kg BW dose of CSN1S2 
Protein goat milk; AFC1000 = AFC1.000 = acute female 1.000 mg/kg BW dose 
of CSN1S2 Protein goat milk; and AFC2.000 = acute female 2.000 mg/kg BW 
dose of CSN1S2 Protein goat milk. 
3.2 14-day Acute Toxicity Study 
In the acute toxicity testing of the male rats there were no differences in the 
relative weight of the brain, heart, liver, thymus, spleen, kidneys, adrenals, 
testes, stomach and intestines between treatment groups (P > 0.05). Only the 
lung weight at the dose of 4000 mg/kg BW was significantly higher compared 
to the control group (Table 1). The histological performance of the lung tissue 
also showed no abnormal changes in cell morphology (data not shown). The 
respiratory rate of the animals showed no symptoms of the respiratory 
distressed syndrome. 
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Table 1 Relative organ weight of male rats in 14-day acute toxicity test of 
caprine CSN1S2 protein from fresh milk. 
Organs Doses of Caprine CSN1S2 Protein (mg/kg BW) 0 500 1000 2000 4000 
Brain 0.70 ± 0.08 0.72 ± 0.04 0.80 ± 0.12 0.70 ± 0.09 0.77 ± 0.09 
Heart 0.27 ± 0.02 0.28 ± 0.08 0.34 ± 0.07 0.34 ± 0.07 0.36 ± 0.07 
Liver 3.13 ± 1.11 3.04 ± 0.56 2.95 ± 0.59 3.38 ± 0.65 3.41 ± 0.46 
Thymus 0.18 ± 0.12 0.22 ± 0.09 0.29 ± 0.13 0.24 ± 0.08 0.22 ± 0.09 
Spleen 0.22 ± 0.06 0.23 ± 0.69 0.27 ± 0.07 0.24 ± 0.05 0.27 ± 0.07 
Kidney 0.68 ± 0.13 0.55 ± 0.21 0.71 ± 0.08 0.73 ± 0.07 0.79 ± 0.10 
Adrenal 0.05 ± 0.08 0.05 ± 0.04 0.10 ± 0.11 0.06 ± 0.05 0.10 ± 0.07 
Lung 0.45 ± 0.04 0.52 ± 0.11 0.59 ± 0.10 0.56 ± 0.09 0.64 ± 0.07a 
Testes 2.28 ± 1.10 1.83 ± 0.77 2.56 ± 0.38 2.73 ± 0.70 2.78 ± 0.50 
Stomach 0.73 ± 0.08 0.65 ± 0.09 0.69 ± 0.13 0.77 ± 0.20 0.82 ± 0.16 
Intestine 2.88 ± 0.26 2.75 ± 0.24 3.20 ± 0.41 3.18 ± 0.69 3.43 ± 0.61 
Note: Data presented as average ± standard deviation; a P < 0.05 the lung weight in the 
4000-dose group was higher compared to the control group. 
The acute toxicity testing of the female rats also displayed no differences in 
relative weight of the brain, heart, liver, thymus, spleen, kidneys, adrenals, 
ovarian, stomach, lungs and intestines between the treatment groups (P > 0.05), 
as shown in Table 2. 
Table 2 Relative organ weight of female rats in 14 day acute toxicity test of 
caprine CSN1S2 protein from fresh milk. 
Organs Doses of Caprine CSN1S2 Protein (mg/kg BW) 0 500 1000 2000 4000 
Brain 0.99 ± 0.15 0.89 ± 0.32 0.96 ± 0.09 0.92 ± 0.16 0.99 ± 0.06 
Heart 0.36 ± 0.09 0.31 ± 0.06 0.32 ± 0.08 0.34 ± 0.03 0.35 ± 0.04 
Liver 3.72 ± 0.47 3.46 ± 0.82 3.59 ± 0.65 3.15 ± 0.27 3.62 ± 0.39 
Thymus 0.31 ± 0.07 0.25 ± 0.05 0.29 ± 0.05 0.27 ± 0.05 0.31 ± 0.08 
Spleen 0.31 ± 0.12 0.27 ± 0.06 0.30 ± 0.06 0.27 ± 0.01 0.30 ± 0.05 
Kidneys 0.73 ± 0.12 0.72 ± 0.16 0.72 ± 0.05 0.77 ± 0.04 0.76 ± 0.13 
Adrenals 0.05 ± 0.08 0.06 ± 0.04 0.06 ± 0.02 0.09 ± 0.01 0.10 ±0.04 
Lungs 0.69 ± 0.17 0.59 ± 0.13 0.67 ± 0.038 0.69 ± 0.06 0.69 ± 0.11 
Ovaries 0.78 ± 0.34 0.69 ± 0.18 0.67 ± 0.142 0.67 ± 0.11 0.77 ± 0.16 
Stomach 0.94 ± 0.13 0.94 ± 0.25 0.87 ± 0.136 0.93 ± 0.07 0.87 ± 0.17 
Intestines 3.91 ± 0.56 3.69 ± 0.80 4.04 ± 0.76 3.06 ± 0.67 3.86 ± 0.61 
Note: Data presented as average ± standard deviation. 
3.3 28-day sub-chronic Toxicity Study   
In the sub-chronic toxicity study, the male rats showed no differences in the 
relative weight of the brain, heart, liver, thymus, spleen, kidneys, adrenals, 
testes, stomach and intestines between treatment groups (P > 0.05). However, 
the obtained liver weight was significantly lower at the dose of 2000 mg/kg BW 
(2.80 ± 0.60g) compared to the control (P < 0.05), as can be seen in Table 3.  
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Table 3 The relative organ weight for male rats in 28-day sub-chronic toxicity 
test of caprine CSN1S2 protein from fresh milk. 
Organs Doses of Caprine CSN1S2 Protein (mg/kg BW) 0 500 1000 2000 
Brain 0.76 ± 0.08 0.75 ± 0.04 0.87 ± 0.25 0.71 ± 0.03 
Heart 0.36 ± 0.05 0.36 ± 0.06 0.36 ± 0.07 0.33 ± 0.05 
Liver 3.09 ± 0.39 3.47 ± 0.35 3. 60 ± 0.54 2.80 ± 0.6a 
Thymus 0.19 ± 0.06 0.19 ± 0.05 0.15 ± 0.05 0.18 ± 0.04 
Spleen 0.24 ± 0.03 0.25 ± 0.05 0.28 ± 0.09 0.26 ± 0.06 
Kidneys 0.67 ± 0.04 0.69 ± 0.06 0.74 ± 0.12 0.65 ± 0.06 
Adrenals 0.054 ± 0.02 0.04 ± 0.01 0.04 ± 0.02 0.05 ± 0.01 
Lungs 0.62 ± 0.21 0.61 ± 0.16 0.60 ± 0.08 0.51 ± 0.08 
Testes 2.52 ± 0.72 2.64 ± 0.79 2.63 ± 0.87 2.86 ± 1.02 
Stomach 0.79 ± 0.07 0.80 ± 0.03 1.25 ± 0.61 0.79 ± 0.10 
Pancreas 0.34 ± 0.11 0.35 ± 0.08 0.29 ± 0.13 0.27 ± 0.07 
Note: Data presented as average ± standard deviation; a P < 0.05 the liver weight for the 
2000-dose group was lower than that for the other groups. 
Similar to the relative weight of some organs of the male rats, the sub-chronic 
toxicity test showed that in the female rats there were no statistical differences 
in the relative weight of the brain, heart, liver, thymus, spleen, kidneys, lungs, 
adrenals, ovaries, gastric tracts and pancreas between groups (P > 0.05), as can 
be seen in Table 4. 
Table 4 The relative organ weight for female rats in 28-day sub-chronic 
toxicity test of caprine CSN1S2 protein from fresh milk. 
Organs Doses of Caprine CSN1S2 Protein (mg/kg BW) 0 500 1000 2000 
Brain 0.92 ± 0.12 0.94 ± 0.07 0.915 ± 0.17 0.90 ± 0.04 
Heart 0.33 ± 0.07 0.34 ± 0.04 0.32 ± 0.03 0.38 ± 0.046 
Liver 3.10 ± 0.47 3.21 ± 0.69 3.63 ± 0.52 3.43 ± 0.25 
Thymus 0.25 ± 0.46 0.26 ± 0.07 0.27 ± 0.08 0.20 ± 0.07 
Spleen 0.26 ± 0.06 0.26 ± 0.04 0.27 ± 0.04 0.28 ± 0.09 
Kidneys 0.70 ± 0.87 0.73 ± 0.15 0.74 ± 0.13 0.65 ± 0.18 
Adrenals 0.10 ± 0.10 0.11 ± 0.13 0.11 ± 0.13 0.13 ± 0.12 
Lungs 0.71 ± 0.19 0.74 ± 0.24 0.61 ± 0.13 0.54 ± 0.24 
Ovaries 0.79 ± 0.26 0.81 ± 0.23 0.88 ± 0.38 0.72 ± 0.23 
Stomach 0.95 ± 0.15 0.97 ± 0.89 0.91 ± 0.07 0.88 ± 0.16 
Pancreas 0.42 ± 0.12 0.45 ± 0.16 0.42 ± 0.17 0.37 ± 0.14 
Note: Data presented on average ± standard deviation. 
All hematological data (Tables 5 and 6) and clinical chemistry data (Tables 7 
and 8) show no significant differences between groups of both sexes (P > 0.05). 
The caprine casein protein from fresh milk was not potentially toxic after the 28 
day sub-chronic toxicity test and there were no treatment-related changes in 
hematological and clinical test parameters.  
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Table 5 Hematological characterization of male rat blood in 28-day sub-
chronic toxicity test of caprine CSN1S2 protein from fresh milk. 
Hematological 
Parameters 
Doses of Caprine CSN1S2 Protein (mg/kg BW) 
0 500 1000 2000 
Hemoglobin (g/dl) 15.20 ± 0.95 17.47 ± 6.52 15.266 ± 4.00 14.00 ± 1.97 
WBC (x 103/µL) 29.00 ± 0.11 43.467 ± 6.99 66.00 ± 4.10 37.93 ± 6.18 
Hematocrit (%) 28.50 ± 0.74 27.13 ± 15.38 28.33 ± 17.79 25.67 ± 18.70 
Trombocyte  
(x 103/L) 
1160000 ± 
150000 
1358000 ± 
414231.8 
1293333.33 ± 
481307.9 
1067333.33 ± 
330165.6 
RBC (x 106/µL) 49.70 ± 1.12 43.02 ± 36.17 45.20 ± 3.37 46.10 ± 3.55 
MCV (fL) 60.67 ± 3.60 62.67 ± 10.79 66.33 ± 12.86 61.67 ± 12.42 
MCH (pg) 81.03 ± 34.86 80.93 ±103.20 100.13 ± 137.67 79.63 ± 101.47 
MCHC (g/dL) 117.10 ± 45.73 114.57 ±132.87 129.33 ± 164.08 112.20 ± 127.24 
Note: WBC: white blood cells; RBC: red blood cells; MCV: mean corpuscular volume; 
MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration. 
Table 6 Hematological characterization of female rat blood in 28-day sub-
chronic toxicity test of caprine CSN1S2 protein from fresh milk. 
Hematological 
parameters 
Doses of Caprine CSN1S2 Protein (mg/kg BW) 
0 500 1000 2000 
Hemoglobin (g/dl) 14.33 ± 2.02 14.33 ± 0.81 13.33 ± 1.45 13.53 ± 1.21 
WBC (x 103/µL) 28.00 ± 14.00 23.33 ± 3.05 28.00 ± 2.00 26.00 ± 5.15 
Hematocrit (%) 38.20 ± 4.161 36.53 ± 0.611 34.80 ± 4.39 35.33 ± 2.48 
Trombocyte  
(x 103/L) 
1038000 ± 
196611.3 
818000 ± 
172835.2 
906000 ± 
213100.0 
1070666.67 ± 
158396 
RBC (x 106/µL) 26.80 ± 0.45 26.43 ± 34.62 24.13 ± 30.90 26.42 ± 35.84 
MCV (fLl) 58.00 ± 2.65 56.00 ± 1.00 56.00 ± 2.645 58.00 ± 2.00 
MCH (pg) 21.70 ± 1.65 22.00 ± 0.69 21.50 ± 0.70 22.37 ± 1.44 
MCHC (g/dL) 37.30 ± 1.32 39.23 ± 1.50 38.30 ± 1.22 38.47 ± 1.72 
Note: WBC: white blood cells; RBC: red blood cells; MCV: mean corpuscular volume; 
MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration. 
Table 7 Clinical characteristics of male rat blood serum in 28-day sub-chronic 
toxicity test of caprine CSN1S2 protein from fresh milk. 
Level Doses of Caprine CSN1S2 Protein (mg/kg BW) 0 500 1000 2000 
Glucose (mg/dL) 78.00 ± 32.05 49.00 ± 21.93 50.67 ± 20.50 51.00 ± 11.14 
TCHO (mg/dL) 73.33 ± 16.01 62.67 ± 17.62 83.33 ± 20.60 73.33 ± 9.24 
Triglyceride (mg/dL) 92.33 ± 22.59 76.67 ± 45.28 90.00 ± 32.19 75 ± 25.63 
BUN (mg/dL) 24.43 ± 2.48 20.93 ± 3.86 27.83 ± 10.22 18.27 ± 4.37 
Creatinin (mg/dL) 0.70 ± 0.06 0.75 ± 0.25 0.64 ± 0.13 0.64 ± 0.01 
Uric acid (mg/dL) 3.77 ± 1.10 3.27 ± 0.99 15.87 ± 23.50 2.40 ± 0.43 
ALP (IU/dL) 288.00 ± 52.51 316.33 ± 170.12 253.00 ± 143.81 260.00 ± 38.74 
AST (IU/dL) 179.33 ± 51.08 157.33 ± 58.77 183.33 ± 76.27 168.67 ± 87.68 
ALT (IU/dL) 56.00 ± 20.81 61.33 ± 35.44 67.67 ± 48.95 90.33 ± 52.50 
Total Protein (g/dL) 10.10 ± 0.49 9.02 ± 1.99 8.51 ± 0.66 8.78 ± 0.29 
Bilirubin (mg/dL) 1.36 ± 0.00 1.46 ± 0.25 1.06 ± 0.13 1.36 ± 0.45 
Note: TCHO: total cholesterol; BUN: blood urea nitrogen; ALP: alkaline phosphatase; AST: 
aspartate aminotransferase; ALT: alanine aminotransferase. 
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Table 8 Clinical characteristics of female rat blood serum in 28-day sub-
chronic toxicity test of caprine CSN1S2 protein from fresh milk. 
Level Doses of Caprine CSN1S2 Protein (mg/kg BW) 0 500 1000 2000 
Glucose (mg/dL) 59.67 ± 29.36 65.67 ± 12.50 64.00 ± 19.16 77.67 ± 9.81 
TCHO (mg/dL) 71.67 ± 2.31 70.67 ± 18.58 80.33 ± 20.01 70.33 ± 4.51 
Triglyceride(mg/dL) 78.67± 35.92 87.33 ± 35.47 87.67 ± 31.08 139.67 ± 75.05 
BUN (mg/dL) 26.93 ± 6.48 30.47 ± 8.19 26.57 ± 4.31 25.83 ± 0.12 
Creatinin (mg/dL) 1.05 ± 0.23 1.09 ± 0.69 0.96 ± 0.50 1.01 ± 0.43 
Uric acid (mg/dL) 3.97 ± 1.15 3.00 ± 1.10 4.00 ± 2.55 3.50 ± 1.48 
ALP (IU/dL) 235.67 ± 130.20 145.33 ± 40.82 209.33 ± 142.53 218.00 ± 136.47 
AST (IU/dL) 178.33 ± 68.122 213.33 ± 45.08 199.67 ± 5.77 154.333 ± 43.29 
ALT (IU/dL) 77.67 ± 35.30 61.67 ± 29.36 64.00 ± 30.05 71.33 ± 15.57 
Total Protein (g/dL) 8.92 ± 0.89 9.76 ± 1.75 9.65 ± 1.75 10.36 ± 1.39 
Bilirubin (mg/dL) 1.26 ± 0.37 1.06 ± 0.14 0.96 ± 0.16 1.22 ± 0.29 
Note: TCHO: total cholesterol; BUN: blood urea nitrogen; ALP: alkaline phosphatase; AST: 
aspartate aminotransferase; ALT: alanine aminotransferase. 
4 Discussion  
Our previous study showed that caprine CSN1S2 protein is able to stimulate 
ileum toxicity up to 2000 mg/kg body weight dosage. At a dose of 2 mg/kg 
body weight, CSN1S2 from goat milk is able to decrease the severity scoring, 
TNF-a, and RAGE expression in a complete Freund’s adjuvant induced 
rheumatoid arthritis model in rats. Besides, this compound also acts as anti-
osteoporotic agent [6,12,15]. In this study, acute and chronic toxicity testing of 
male and female rats treated with caprine CSN1S2 protein from fresh milk was 
conducted. In the 14-day acute toxicity test, the daily food and water 
consumption was normal. Body weight and daily body weight (data not shown) 
of the rats in all groups increased slightly. This result indicates no abnormal 
effects from treatment with caprine CSN1S2 protein from fresh milk in both rat 
sexes. Recently, a study using bovine CSN1S1 protein reported that body 
weight, daily body weight gain, food and water consumption were unaffected 
by the treatment with a single oral dose of 2000 mg/kg of bovine alpha-S1 
casein hydrolysate [13]. 
The most sensitive toxicity study indicators are organ weight – in the absence of 
morphological changes – and age, sex, animal strain, and experimental 
conditions [16]. In the acute toxicity tests, interval doses of caprine CSN1S2 
protein from fresh milk were used. Our results indicate that the male rats’ lung 
weight gain at a high dose (4000 mg/kg BW) may be seen as an early 
lung/respiratory response caused by the caprine casein protein of fresh milk 
consumption. Meanwhile, the respiratory rate data show that none of the animal 
groups displayed any symptoms related to the respiratory distress syndrome. 
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Caprine casein protein from fresh milk may cause fluid to accumulate in the 
rats’ lungs and oxygen levels in the blood to be normal, respectively. 
The highest organ weight gain in the male rats in the 28-day sub-chronic 
toxicity test was not abnormal, although the liver weight was slightly elevated at 
doses of 500-1000 mg/kg BW and declined at a dose of 2000 mg/kg BW. These 
slight changes in the organ weight of the animals are probably not to be 
considered treatment effects because these values are within the normal weight 
ranges [17,18]. Another study predicted elevation of the liver weight in less than 
7 days duration because of the induction of potent hepatic enzyme compounds 
[19]. Meanwhile, the female rat organs displayed no change in the relative 
weights of the brain, heart, liver, thymus, spleen, kidneys, lungs, adrenals, 
ovaries, gastric tracts and pancreas between groups. According to this study, it 
can be recommended that milk casein protein toxicity studies based on the 
weight of organs may focus on detecting test article-related effects, such as 
steroid and non-steroid hormone levels, hepatic enzyme compounds, or other 
environmental factors.  
The hematopoietic systems are very sensitive to toxic compounds and are 
subject to change due to the intake of toxic compounds from plants or food. 
Changes in the hematopoietic system have a high predictive value for toxicity in 
humans when data are translated from animal studies. Bone marrow activity 
status and intravascular effects can be monitored through changes in 
hematological parameters [18,20,21]. In this study, several hematological 
parameters showed no significant changes between the treatment groups and the 
control group. This indicates that CSN1S2 is not toxic to the hematopoietic 
system.  
Analysis of blood chemistry was performed to assess toxicity to the functions of 
the pancreas (glucose), kidneys (BUN, creatinine) and liver (SGOT, SGPT, 
ALP, total protein, albumin, and bilirubin) [22-24]. This study found no 
significant changes in these clinical chemistry parameters in any of the male and 
female rats treated with caprine CSN1S2 protein from fresh milk. This indicates 
that the oral administration of sub-chronic caprine CSN1S2 protein from fresh 
milk does not interfere with the function of the pancreas, kidneys or liver. In 
addition, providing caprine CSN1S2 protein from fresh milk also does not 
affect cholesterol and triglyceride levels in the lipid metabolism. Our studies 
confirmed that a safe dose of caprine CSN1S2 protein from fresh milk from 
local goats is up to 2000 mg/kg BW. Recently, milk casein protein toxicity 
effect studies have shown that a daily dose of 1000-2000 mg/kg of body weight 
for 4 weeks is well tolerated in rats. No systemic evidence was found for 
mortality or alterations of the hematological or clinical pathology, and there 
were no changes in body weight or body weight gain after daily consumption of 
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casein for 4 weeks [17]. Our investigation of the rats’ small intestine 
microstructures and mineral profiles showed no abnormalities for a dose of 
2000 mg/kg BW, i.e. the maximum recommended daily dose of CSN1S2 
protein isolated from casein protein goat milk [12]. 
5 Conclusion 
From this study, it can be concluded that caprine CSN1S2 protein from fresh 
milk of local goats does not cause symptoms or signs of toxicity and can be 
recommended as safe for food consumption. Caprine CSN1S2 protein from 
fresh milk also does not trigger lethal effects  or changes in hematological and 
blood chemistry parameters. 
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